Archive for November, 2007

Portopulmonary Hypertension: Bosentan Could Give A Survival Advantage

Tuesday, November 27th, 2007

The term portopulmonary hypertension refers to the development of pulmonary arterial hypertension (PAH) in patients with liver disease and portal hypertension. Approximately 1-2% of patients with chronic liver disease develop portopulmonary hypertension and the mortality associated with this condition reaches up to 50% within one year after diagnosis. [click link for full article]

More: continued here

When Treating High Blood Pressure, Simplicity Is Best

Saturday, November 24th, 2007

A simplified, step-care protocol for treating high blood pressure was more effective than guidelines-based practice in helping people reduce their blood pressure, according to late-breaking clinical trial results presented at the American Heart Association’s Scientific Sessions 2007. [click link for full article]

More: continued here

People With High Blood Pressure, Heart Disease Should Avoid Energy Drinks

Saturday, November 24th, 2007

Downing an “energy drink” may boost blood pressure as well as energy, researchers said in a small study presented at the American Heart Association’s Scientific Sessions 2007.In the study, conducted by Wayne State University researchers, blood pressure and heart rate levels increased in healthy adults who drank two cans a day of a popular energy drink. [click link for full article]

More: continued here

For Identifying Key Components Of Blood Pressure Control, Emory Scientist Honored

Saturday, November 24th, 2007

The American Heart Association awarded its 2007 Basic Research Prize to Kenneth E. Bernstein, M.D., of Emory University in Atlanta, for “seminal discoveries contributing vital understanding of basic mechanisms involved in blood pressure control.”Bernstein was honored for his work identifying and cloning the angiotensin-converting enzyme (ACE) gene and angiotensin II type 1 receptor, along with that receptor’s unique signaling pathway. [click link for full article]

More: continued here

Hypertension Treatment In Mexico Improves With Expanded Health Insurance

Saturday, November 24th, 2007

Mexico’s new health insurance program, Seguro Popular, which was created to extend health insurance to the nation’s 50 million uninsured by 2010, is having a positive effect on coverage of antihypertensive treatment in that country, according to a study published in the October 27 issue of British Medical Journal. [click link for full article]

More: continued here

Elderly With Hypertension Less Likely To Get Lifestyle Modification Advice From Doctors

Saturday, November 24th, 2007

People older than 60 with high blood pressure are less likely than other groups of patients to receive advice from their doctors about lifestyle modifications that can help lower their blood pressure, a study by UNC researchers concludes. [click link for full article]

More: continued here

For Trials Documenting CVD Burden Chicago Scientist Honored

Saturday, November 24th, 2007

The American Heart Association awarded its Population Research Prize to Paul K. Whelton, M.D., of Loyola University in Chicago, for pioneering population trials that are the informational basis for much of today’s fight against cardiovascular diseases.”For more than two decades, Dr. [click link for full article]

More: continued here

Novel Approach To Blood Pressure Control

Saturday, November 24th, 2007

A hypertension vaccine could be an important alternative to conventional drug therapy because of patients’ inconsistent drug intake — if further research supports results from a small study testing the safety and tolerability of a vaccine.”Despite the fact that effective drugs are available, only about one out of four people has their blood pressure successfully controlled,” said Juerg Nussberger, M.D. [click link for full article]

More: continued here

A New Method Allows For The Early Diagnosis Of Pulmonary Hypertension

Saturday, November 24th, 2007

Researchers at the University of Granada (UGR) from the Systemic Autoimmune Diseases Unit and the Cardiology Service of the Hospital ClĂ­nico San Cecilio in Granada have developed an innovative system which will help doctors make the earliest diagnosis of pulmonary hypertension possible, which is the main cause of death for patients suffering from scleroderma, a rare disease which affects approximately 1,200 out of every million people. [click link for full article]

More: continued here

New Findings Provide Insight Into Treatment Of Hypertension In Mexican Americans

Saturday, November 24th, 2007

Researchers have reported a possible explanation for lower rates of blood pressure control in Mexican Americans, along with a potential way of treating the condition. A new study showed that blood vessel cells from Mexican Americans had lower production of the natural blood vessel relaxant, nitric oxide (NO), in comparison to cells from non-Hispanic whites. NO is an essential substance in healthy blood vessels and is required for regulating normal blood pressure. [click link for full article]

More: continued here

Archives






Categories



Blogroll

Meta